Evaluation of ABT-751 against childhood cancer models in vivo.

Morton, Christopher L; Favours, Edward G; Mercer, Kimberly S; Boltz, Claire R; Crumpton, Jeri Carol; Tucker, Chandra; Billups, Catherine A; Houghton, Peter J

Morton, Christopher L; Favours, Edward G; Mercer, Kimberly S; Boltz, Claire R; Crumpton, Jeri Carol; Tucker, Chandra; Billups, Catherine A; Houghton, Peter J.

Affiliation

Morton CL; Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 North Lauderdale St, Memphis, TN 38105, USA.

Invest New Drugs ; 25(4): 285-95, 2007 Aug.

Article in En | MEDLINE | ID: mdl-17384918

Subject(s)

Antimitotic Agents/therapeutic use; Neoplasms, Experimental/drug therapy; Sulfonamides/therapeutic use; Animals; Antimitotic Agents/administration & dosage; Cell Line, Tumor; Child; Female; Humans; Mice; Mice, SCID; Pediatrics; Sulfonamides/administration & dosage; Xenograft Model Antitumor Assays

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Sulfonamides / Antimitotic Agents / Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals / Child / Female / Humans Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links